Clinical Trials Browser

Phase 2 × Carcinoma, Hepatocellular × TLC 388 × Clear all

NCT02267213 2019-02-26

Efficacy and Safety Study of TLC388 to Advanced Hepatocellular Carcinoma

Phase 2 Terminated

Gastrointestinal

Carcinoma, Hepatocellular